Instem Release: Clinical Research Center In Hungary Purchases ALPHADAS For New Phase I Unit
6/16/2014 10:32:31 AM
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Clinical Research Units Hungary (“CRU Hungary”) has purchased the entire ALPHADAS® clinical trials software solution suite for a new Phase I facility being constructed in eastern Europe.
Help employers find you! Check out all the jobs and post your resume.
comments powered by